It has recently been shown that NF-κB enhances the expression of T cell chemokines CCL2 and CCL5 to increase T cell tumor infiltration and tumor rejection in mouse tumor models and human lung cancer patients [52]. The gene discussed is CCL5; the disease is neoplasm.